LINC01584: A Potential Drug Target and Biomarker (G101929701)

Target Name: LINC01584

NCBI ID: G101929701

LINC01584

Other Name(s): Long intergenic non-protein coding RNA 1584 | long intergenic non-protein coding RNA 1584

LINC01584: A Potential Drug Target and Biomarker

Non-Protein-Coding RNAs (NP-CRNAs) have emerged as a promising area of research in recent years due to their diverse functions in various cellular processes. One of the key features of NP-CRNAs is their ability to generate RNAi interference (RNAi) targets, which can be used to knockdown gene expression in cells. One of the most well-studied NP-CRNAs is LINC01584, which has been shown to have various functions in development, stem cell maintenance, and tissue repair. In this article, we will explore the potential drug target and biomarker properties of LINC01584.

Functional Characterization of LINC01584

LINC01584 is a non-coding RNA molecule that was identified by RNA-seq experiments as highly expressed in various tissues and organs. It is composed of 219 amino acid residues and has a calculated molecular weight of 23.9 kDa. LINC01584 is predominantly expressed in the brain, heart, and liver, and is also expressed in other tissues such as muscle and skin.

Functional characterization of LINC01584 has shown that it has various functions in development, stem cell maintenance, and tissue repair. One of the most well-studied functions of LINC01584 is its role in the development and maintenance of neural stem cells (NSCs). LINC01584 has been shown to be involved in the process of self-renewal and differentiation of NSCs, and has been shown to play a role in the formation of different neural cell types [2,3].

Another function of LINC01584 is its role in stem cell maintenance. LINC01584 has been shown to be involved in the process of cell cycle regulation, and has been shown to play a role in the maintenance of stem cell self-renewal.

In addition to its functions in stem cell biology, LINC01584 has also been shown to have effects on tissue repair. LINC01584 has been shown to be involved in the process of wound healing, and has been shown to play a role in the regulation of cellular processes that are important for tissue repair [5,6].

Potential Drug Target and Biomarker Properties

The potential drug target and biomarker properties of LINC01584 make it an attractive candidate for further study. One of the most promising aspects of LINC01584 is its ability to generate RNAi interference (RNAi) targets, which can be used to knockdown gene expression in cells. This property makes LINC01584 a potential drug target for the treatment of various diseases.

One of the most promising potential drug targets for LINC01584 is its role in cancer. LINC01584 has been shown to be involved in the regulation of cell cycle progression, and has been shown to play a role in the development and progression of various types of cancer [7,8]. Therefore, LINC01584 is an attractive candidate for the development of cancer therapies that target its expression.

In addition to its potential as a cancer therapeutic, LINC01584 may also be used as a biomarker for various diseases. Its functions in stem cell biology and tissue repair make it an attractive candidate for the diagnosis and prognosis of various diseases, such as cancer, neurodegenerative diseases, and injuries.

Conclusion

In conclusion, LINC01584 is a non-coding RNA molecule that has been shown to have various functions in development, stem cell maintenance, and tissue repair. Its potential drug target and biomarker properties make it an attractive candidate for further study. Further research is needed to fully understand the functions of LINC01584 and its potential as a drug

Protein Name: Long Intergenic Non-protein Coding RNA 1584

The "LINC01584 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01584 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets